CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Children's Hospital Association Shares Recommendations With CMS to Mitigate Impact of H.R. 1 on Kids
Children's Hospital Association's End of the Year Appropriations Letter
CHA, Ronald McDonald House Global Launch Data Initiative to Improve Health Outcomes for Children
Children's Hospital Association Shares Recommendations With CMS to Mitigate Impact of H.R. 1 on Kids
As major Medicaid providers, children’s hospitals rely on state directed payments (SDPs) to ensure access to care for children.
Nov. 21, 2025
Children's Hospital Association's End of the Year Appropriations Letter
In order to secure America’s future, children’s health must be a national priority.
Nov. 21, 2025
CHA, Ronald McDonald House Global Launch Data Initiative to Improve Health Outcomes for Children
The first-of-its-kind partnership is designed to help forecast demand and identify opportunities to better support children’s hospital patients and their families.
Nov. 19, 2025
